These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1654556)

  • 21. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque.
    Diani AR; Mulholland MJ; Shull KL; Kubicek MF; Johnson GA; Schostarez HJ; Brunden MN; Buhl AE
    J Clin Endocrinol Metab; 1992 Feb; 74(2):345-50. PubMed ID: 1309834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia.
    McConnell JD; Wilson JD; George FW; Geller J; Pappas F; Stoner E
    J Clin Endocrinol Metab; 1992 Mar; 74(3):505-8. PubMed ID: 1371291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
    Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
    Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of a 5 alpha-reductase inhibitor on androgen-mediated growth of the dog prostate.
    Wenderoth UK; George FW; Wilson JD
    Endocrinology; 1983 Aug; 113(2):569-73. PubMed ID: 6872940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
    Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
    J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    Brooks JR; Berman C; Nguyen H; Prahalada S; Primka RL; Rasmusson GH; Slater EE
    Prostate; 1991; 18(3):215-27. PubMed ID: 1850515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
    Rittmaster RS; Stoner E; Thompson DL; Nance D; Lasseter KC
    J Androl; 1989; 10(4):259-62. PubMed ID: 2550402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of rat ventral prostate to a new and novel 5 alpha-reductase inhibitor.
    Brooks JR; Baptista EM; Berman C; Ham EA; Hichens M; Johnston DB; Primka RL; Rasmusson GH; Reynolds GF; Schmitt SM; Arth GE
    Endocrinology; 1981 Sep; 109(3):830-6. PubMed ID: 7262023
    [No Abstract]   [Full Text] [Related]  

  • 30. PNU 157706, a novel dual type I and II 5alpha-reductase inhibitor.
    di Salle E; Giudici D; Radice A; Zaccheo T; Ornati G; Nesi M; Panzeri A; Délos S; Martin PM
    J Steroid Biochem Mol Biol; 1998 Feb; 64(3-4):179-86. PubMed ID: 9605412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of flutamide and finasteride on rat testicular descent.
    Spencer JR; Torrado T; Sanchez RS; Vaughan ED; Imperato-McGinley J
    Endocrinology; 1991 Aug; 129(2):741-8. PubMed ID: 1677329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment.
    Astancolle S; Guidetti G; Pinna C; Corti A; Bettuzzi S
    J Endocrinol; 2000 Nov; 167(2):197-204. PubMed ID: 11054633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-related changes in brain and pituitary 5 alpha-reductase with finasteride (Proscar) treatment.
    Lephart ED
    Neurobiol Aging; 1995; 16(4):647-50. PubMed ID: 8544916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
    Fleshner NE; Trachtenberg J
    J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes.
    Mahendroo MS; Cala KM; Hess DL; Russell DW
    Endocrinology; 2001 Nov; 142(11):4652-62. PubMed ID: 11606430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride.
    Makridakis N; Reichardt JK
    J Mol Endocrinol; 2005 Jun; 34(3):617-23. PubMed ID: 15956333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finasteride: a slow-binding 5 alpha-reductase inhibitor.
    Faller B; Farley D; Nick H
    Biochemistry; 1993 Jun; 32(21):5705-10. PubMed ID: 8389191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of finasteride on the rat ventral prostate.
    Shao TC; Kong A; Marafelia P; Cunningham GR
    J Androl; 1993; 14(2):79-86. PubMed ID: 8390428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A; Hayashi N; Sugimura Y; Cunha GR; Kawamura J
    Prostate; 1996 Jul; 29(1):1-14. PubMed ID: 8685049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.